StoxChandan Healthcare Limited
NSE: CHANDAN · Unclassified
Ask the data
Instant answers about Chandan Healthcare Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY25 | FY26 | |
|---|---|---|
| Revenue | 230.1 | 276.4 |
| EBITDA | 41.3 | 52.6 |
| Operating margin | 18.0% | 19.0% |
| Interest | 4.6 | 5.9 |
| Depreciation | 6.7 | 9.8 |
| Profit before tax | 32.1 | 38.3 |
| Tax | 8.6 | 9.7 |
| Net profit | 22.2 | 27.1 |
| EPS ₹ | 10.78 | 11.07 |
| Operating cash flow | -29.1 | 16.2 |
| Capex | 38.7 | 42.6 |
| Dividend paid | 3.0 | 0.0 |
| Total assets | 210.6 | 289.5 |
| Equity | 122.6 | 171.0 |
Half-yearly performance
last 4 half years · ₹ crore| H1 FY25* | H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|---|
| Revenue | 110.5 | 119.7 | 135.8 | 140.6 |
| Operating profit | 19.8 | 21.5 | 28.3 | 24.3 |
| Operating margin | 18.0% | 18.0% | 20.8% | 17.3% |
| Other income | 1.0 | 1.1 | 1.7 | 2.6 |
| Interest | 2.2 | 2.4 | 2.8 | 3.1 |
| Depreciation | 3.2 | 3.5 | 4.9 | 4.8 |
| Profit before tax | 15.4 | 16.7 | 22.3 | 16.0 |
| Tax | 4.1 | 4.5 | 5.8 | 4.0 |
| Net profit | 10.6 | 11.5 | 15.6 | 11.5 |
| EPS ₹ | 5.18 | 5.60 | 6.38 | 4.69 |
| Revenue YoY | — | — | 22.9% | 17.5% |
| Profit YoY | — | — | 46.6% | -0.6% |
Returns & margins
trailing-twelve-month, per half year| H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|
| ROE | 18.1% | 19.6% | 15.8% |
| ROCE | 21.5% | 21.5% | 19.6% |
| Net margin | 9.6% | 10.6% | 9.8% |
| EBITDA margin | 18.0% | 19.5% | 19.0% |
| Debt / equity | 0.39 | 0.48 | 0.31 |
| Interest coverage | 8.00 | 8.52 | 7.51 |
| Asset turnover | 1.09 | 0.94 | 0.95 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '25 | SEP '25 | MAR '26 | |
|---|---|---|---|
| Share capital | 24.4 | 24.4 | 24.4 |
| Other equity / reserves | 98.2 | 113.8 | 145.4 |
| Total equity | 122.6 | 138.2 | 171.0 |
| Borrowings | 48.2 | 66.8 | 53.8 |
| Current liabilities | 56.9 | 99.3 | 77.3 |
| Non-current liabilities | 27.3 | 30.9 | 36.0 |
| Total assets | 210.6 | 273.2 | 289.5 |
| Property, plant & equipment | 71.9 | 86.8 | 96.8 |
| Investments | 1.1 | 46.6 | 20.0 |
| Inventories | 31.4 | 30.9 | 33.7 |
| Receivables | 46.7 | 67.5 | 86.4 |
| Cash & equivalents | 6.2 | 16.8 | 3.6 |
Cash flow
annual · ₹ crore · line = free cash flow| FY25 | FY26 | |
|---|---|---|
| Cash from operations | -29.1 | 16.2 |
| Cash from investing | -35.8 | -39.9 |
| Cash from financing | 67.1 | 21.1 |
| Capex | 38.7 | 42.6 |
| Free cash flow | -67.8 | -26.4 |
| Dividends paid | 3.0 | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Chandan Healthcare Limited | 573 | 234.50 | 21.2 | 3.35 | 15.8% |
StoxGud checklist: Neutral setup · 5/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Chandan Healthcare Limited?
Chandan Healthcare Limited (CHANDAN) closed at ₹234.50 on NSE on 06 Nov 2026.
What is the market cap of Chandan Healthcare Limited?
₹573 crore at the latest close.
What is the P/E ratio of Chandan Healthcare Limited?
21.2, on trailing-twelve-month earnings from its filings.
How fast is Chandan Healthcare Limited growing?
Chandan Healthcare Limited: Latest-half-year revenue is up 17.5% year on year, profit down 0.6%.
How profitable is Chandan Healthcare Limited?
On a trailing-twelve-month basis return on equity is 15.8%, return on capital employed 19.6%, operating margin 19.0%, net margin 9.8%.
How much debt does Chandan Healthcare Limited have?
Chandan Healthcare Limited is lightly geared: debt to equity is 0.31 with borrowings of ₹54 cr against cash of ₹4 cr (balance sheet of 2026-03-31). Operating profit covers interest 7.5 times.
Financials parsed from Chandan Healthcare Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY25, annual from FY25, balance sheet from Mar '25. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.